Please sign in to follow a disease.

EGFR-positive advanced biliary tract carcinoma

Clinical trials for EGFR-positive advanced biliary tract carcinoma explained in plain language.

Never miss a new study

Get alerted when new EGFR-positive advanced biliary tract carcinoma trials appear

Sign up with your email to follow new studies for EGFR-positive advanced biliary tract carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New hope for bile duct cancer: drug duo targets tough tumors

Disease control Not yet recruiting

This phase II trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy) and pucotenlimab (an immunotherapy)—in 30 adults with advanced biliary tract cancer whose first treatment stopped working. The goal is to see if the combo can shrink tumors and improve sur…

Matched conditions: EGFR-POSITIVE ADVANCED BILIARY TRACT CARCINOMA

Phase 2 • Sponsor: HuiKai Li • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

EGFR-positive advanced biliary tract carcinoma

Get alerted when new EGFR-positive advanced biliary tract carcinoma trials appear

New hope for bile duct cancer: drug duo targets tough tumors